Rosemina Merchant
Gründer bei MEDICENNA THERAPEUTICS CORP.
Vermögen: 7 Mio $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Rosemina Merchant
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
29
| Extinct | Pharmaceuticals: Major | 29 |
| Public Company | Biotechnology | 24 | |
Medicenna Therapeutics, Inc.
 Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Intelligene Expressions, Inc.
1
| Private Company | 1 | |
Intelligenetics, Inc.
 Intelligenetics, Inc. Information Technology ServicesTechnology Services Intelligenetics, Inc. engages in the provision of bioinformatics services. The company is headquartered in Campbell, CA.
1
| Subsidiary | Information Technology Services | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Rosemina Merchant
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Western Ontario | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
Warburg Pincus LLC
 Warburg Pincus LLC Investment ManagersFinance Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York. | Investment Managers | Investment Committee Member Corporate Officer/Principal Private Equity Investor Private Equity Analyst | |
BC Advantage Funds Ltd.
 BC Advantage Funds Ltd. Investment ManagersFinance Founded 2003, BC Advantage Funds (VCC) Ltd is a venture capital firm, headquartered in Canada. | Investment Managers | Chairman Director/Board Member Private Equity Investor | |
| XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director of Finance/CFO Founder Corporate Officer/Principal | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of British Columbia | College/University | Doctorate Degree Corporate Officer/Principal Masters Business Admin | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| SERNOVA CORP. | Biotechnology | Director of Finance/CFO Chairman | |
| University of Calgary | College/University | Graduate Degree Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
| The Johns Hopkins University | College/University | Graduate Degree Corporate Officer/Principal | |
| INTERMUNE INC | Biotechnology | Director/Board Member Director/Board Member | |
| PURE GLOBAL CANNABIS INC. | Pharmaceuticals: Other | Chairman Director/Board Member | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ReSearch Pharmaceutical Services LLC
 ReSearch Pharmaceutical Services LLC Miscellaneous Commercial ServicesCommercial Services ReSearch Pharmaceutical Services LLC provides clinical research services to the bio-pharmaceutical industry. Its services include analytical and product development, clinical operations, data services, medical and regulatory affairs, quality and training services. The company was founded by Daniel M. Perlman in 1998 and is headquartered in Fort Washington, PA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Alita Pharmaceuticals, Inc.
 Alita Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alita Pharmaceuticals, Inc. develops, manufactures and distributes urologic and female healthcare products. It offers product testing, research and development services. The company was founded by Carole S. Ben-Maimon and Warburg Pincus in September 2006 and is headquartered in Radnor, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Simon Fraser University | College/University | Masters Business Admin Doctorate Degree | |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Toronto | College/University | Undergraduate Degree Undergraduate Degree | |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Investment Managers | Chief Investment Officer Chief Investment Officer | |
| University of Saskatchewan | College/University | Undergraduate Degree Undergraduate Degree | |
AFYX Therapeutics AS
 AFYX Therapeutics AS Miscellaneous Commercial ServicesCommercial Services AFYX Therapeutics AS engages in research and development of pharmaceutical drugs. It develops a platform designed to deliver a pharmaceutical drug uni-directional to a mucosal surface. The company was founded in May 2014 and is headquartered in Virum, Denmark. | Miscellaneous Commercial Services | Chairman Chief Executive Officer | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| Brown University | College/University | Corporate Officer/Principal Undergraduate Degree | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Chairman President | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member General Counsel | |
Lions Capital Corp.
 Lions Capital Corp. Investment ManagersFinance Lions Capital Corp (Lions Capital) is a fund management and corporate advisory firm founded in 2003. The firm headquartered in Vancouver, Canada. | Investment Managers | Chairman Chief Executive Officer | |
| ALLON THERAPEUTICS INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| PROOF Centre of Excellence | Chairman | ||
PheroTech International, Inc.
 PheroTech International, Inc. Chemicals: AgriculturalProcess Industries Pherotech International was founded in 1980 and is a Canadian-based revenue producing Life Science company that is a world leader in the development and commercialization of semiochemical and non-toxic insect trapping technologies for pest management in home and garden, forestry, agricultural, structural and commercial applications. Since Pherotech was founded, it has assembled a world-class team of business executives and scientific advisors. Pherotech International offers a wide variety of scientifically-backed leading products with an established distribution network as well as direct sales to large customers that include the U.S. Department of Agriculture, the Canadian Forest Service and large retail chains such as Wal-Mart. The company has an impressive pipeline of new products with strong commercial potential that will allow it to grow profitably and maximize its returns on invested capital for years to come. | Chemicals: Agricultural | Director/Board Member | |
LifeSciences British Columbia
 LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member | |
Genome British Columbia
 Genome British Columbia Miscellaneous Commercial ServicesCommercial Services Genome British Columbia invests in and manages genomics and proteomics research projects. It offers services in human health, environment, agriculture, forestry, mining, energy, aquaculture, and fisheries. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
Prime Trials Ltd.
 Prime Trials Ltd. Miscellaneous Commercial ServicesCommercial Services Prime Trials Ltd. operates clinical laboratories. The company is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | President | |
| NDI Investment Management, Inc. | Chairman | ||
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Medical Specialties | Chief Executive Officer |
Statistik
International
| Kanada | 28 |
| Vereinigte Staaten | 22 |
| Irland | 2 |
| Dänemark | 2 |
Sektoral
| Health Technology | 23 |
| Consumer Services | 11 |
| Commercial Services | 8 |
| Finance | 7 |
| Electronic Technology | 2 |
Operativ
| Director/Board Member | 281 |
| Corporate Officer/Principal | 105 |
| Independent Dir/Board Member | 85 |
| Chairman | 63 |
| President | 45 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Nitin Kaushal | 51 |
| Jonathan Leff | 45 |
| Noah Knauf | 35 |
| Trevor Wong-Chor | 33 |
| Frank Holler | 29 |
| Avtar Dhillon | 25 |
| Chandrakant Panchal | 22 |
| Karen Dawes | 21 |
| Lars Ekman | 21 |
| Jim J. Miller | 19 |
| Alexander R. Giaquinto | 19 |
| Don B. Rix | 18 |
| Nishan de Silva | 18 |
| Alexander Casdin | 17 |
| Kenneth H. Haas | 17 |
- Börse
- Insiders
- Rosemina Merchant
- Unternehmensverbindungen
